Skip to main content
letter
. 2022 Jun 9;104:113–115. doi: 10.1016/j.ejim.2022.06.007

Table 1.

Treatment effects of statins on clinical outcomes in patients with COVID-19.

Outcomes MD (95% CI) RR (95% CI) p-value I2
Length of stay (days) 0.25 (-1.13 to 1.62) - 0.73 84%
ICU admission - 1.72 (0.61 to 4.85) 0.31 59%
Death - 0.90 (0.73 to 1.11) 0.33 0%

MD, mean difference; RR, risk ratio; CI, confidence interval. Negative results for MD indicate decreased length of stay among patients receiving statins.